Clinical Trials Browser

OTHER × Carcinoma, Renal Cell × IT-101 × Clear all

NCT01625936 2018-08-29

CRLX101 Plus Bevacizumab in Advanced RCC

Phase 1 Completed

Carcinoma, Renal Cell, Neoplasm Metastasis